Detection of Helicobacter Pylori in Ulcerative Colitis Patients

Detection of Helicobacter Pylori in Colonic Tissue in Newly Diagnosed Ulcerative Colitis Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03172000

Enrollment

Registered

2017-05-31

Start date

2017-03-01

Completion date

2019-12-31

Last updated

2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

Helicobacter pylori (H. pylori) infection is one of the most common infectious diseases in humans.

Detailed description

Several bacterial and viral agents may have a role in the aetiology of IBD. In theory, H. pylori infection could be involved in IBD by inducing alterations in gastric and/or intestinal permeability or by causing immunological derangements resulting in absorption of antigenic material and autoimmunity via various immunological pathways.

Interventions

DIAGNOSTIC_TESTColonoscopy and biopsy

Colonoscopic biopsy were taken from the rectum, the sigmoid, descending, transverse, ascending colon, and the cecum of each patient.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* newly diagnosed ulcerative colitis

Exclusion criteria

* Other diagnosis

Design outcomes

Primary

Measure	Time frame	Description
Number of patients with Helicobacter	6 months	Number of patients with Helicobacter

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, MD

Sheriefabdelsalam@yahoo.com00201147773440

Backup Contactsherief Abd-Elsalam, Consultant

sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026